Why the 60 Minutes shambles is unlikely to be a one-off incident
Apr 20, 2016 05:58 am UTC| Insights & Views Business
It may be a small indicator of how far journalism standards have fallen at one of Australias great newspapers that a reporter on The Sydney Morning Herald, interviewing me for their online site about the attempted...

How might Big Tobacco react to a rise in cigarette excise?
Apr 20, 2016 05:54 am UTC| Insights & Views Business
There now appears to be bipartisan recognition in Australia of the political stench of cigarettes. Labor governments have taken a dim view of smoking for at least a decade, but now even the Liberal Party is joining the...
Statoil ASA: Statoil's share saving plan allocates shares
Apr 20, 2016 05:30 am UTC| Business
STAVANGER, Norway, April 20, 2016 -- The shares purchased by DNB on behalf of Statoil ASA (OSE: STL, NYSE:STO) on 15 April 2016 for use in the group's Share Saving Plan have on 19 April 2016 been distributed to the...
Basilea awarded contract by BARDA of up to USD 100 million funding for ceftobiprole phase 3 program
Apr 20, 2016 05:23 am UTC| Business
BASEL, Switzerland, April 20, 2016 -- Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today that the Biomedical Advanced Research and Development Authority (BARDA), a division within the U.S. Department of Health and...
Genmab Updates Financial Guidance for 2016
Apr 20, 2016 05:08 am UTC| Business
COPENHAGEN, Denmark, April 20, 2016 -- Company Announcement Genmab improves financial guidance for 2016 Improvement driven by DARZALEX(r) sales Rapid uptake of the product since launch COPENHAGEN, Denmark,...
Audio Pixels Surpasses One Trillion Cycle Tests with Zero Failures
Apr 20, 2016 02:20 am UTC| Business
SYDNEY, Australia, April 20, 2016 -- Dear Sirs, Audio Pixels Holdings Limited (ASX:AKP) (OTC:ADPXY) (NASDAQ International Designation), a leader in digital MEMS loudspeakers, is pleased to announce that its test...
Apr 20, 2016 00:45 am UTC| Business
Anti-dyskinetic Effect Consistent Across Primary and Secondary Outcome Measures EMERYVILLE, Calif., April 19, 2016 -- Adamas Pharmaceuticals, Inc. (Nasdaq:ADMS) today announced positive findings from its lead Phase 3...